DFIG
BIIB icon

Dragon Financial & Investment Group’s Biogen BIIB Stock Holding History

Dragon Financial & Investment Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$208K Sell
589
-467
-44% -$161K 0.24% 21
2018
Q2 		$306K Sell
1,056
-30
-3% -$8.43K 0.35% 21
2018
Q1 		$297K Buy
1,086
+39
+4% +$12.1K 0.27% 22
2017
Q4 		$334K Buy
+1,047
New +$336K 0.3% 22

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Dragon Financial & Investment Group's BIIB Position: Q3 2018 in Review

Dragon Financial & Investment Group reduced its Biogen (BIIB) stake by 44% in Q3 2018, selling an estimated $161K and leaving 589 shares worth $208K. The position accounts for 0.24% of the portfolio, ranked #21.

Dragon Financial & Investment Group first reported a position in BIIB in Q4 2017 and has held it in 4 quarters since. The position peaked at $334K in Q4 2017. 1,145 funds tracked by Wall St. Rank hold BIIB as of Q3 2018.

  • Dragon Financial & Investment Group held 589 shares of Biogen worth $208K as of Q3 2018.
  • Dragon Financial & Investment Group sold 467 Biogen shares in Q3 2018, an estimated $161K.
  • Biogen made up 0.24% of Dragon Financial & Investment Group's portfolio in Q3 2018, its #21 holding.
  • Dragon Financial & Investment Group first reported a position in Biogen in Q4 2017 and has held it in 4 quarters since.
  • Dragon Financial & Investment Group's Biogen position peaked at $334K in Q4 2017.
  • 1,145 funds tracked by Wall St. Rank held Biogen as of Q3 2018.

Based on Dragon Financial & Investment Group's 13F filing for Q3 2018, filed 19 Oct 2018.